Cases of diabetes and high cholesterol levels in Kelantan have seen an increase exceeding the national average indicators, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said based on the ...

In a joint initiative by the Tun Hussein Onn National Eye Hospital and Malaysia’s Ministry of Health, the country’s first Cataract Carnival ...

A new report from global consultancy Kearney and the World Economic Forum’s Global Alliance for Women’s Health—supported by the Gates ...

Achieving zero preventable dengue deaths is no longer an idealistic goal but a realistic one. By taking four simple actions — eliminating ...

A landmark resolution on lung health by Malaysia has been officially adopted by the World Health Organisation (WHO) in conjunction ...

Mental illness, cardiovascular disease, tobacco use, and injuries are now among the leading causes of death and disability in Southeast Asia, according to newly released research from the Institute ...

More than 200 doctors and private general practitioners (GPs) have gathered near the Prime Minister’s Office (PMO) here to protest the mandatory display of drug prices under a law unrelated to the ...

As Malaysia continues to strengthen its position as Southeast Asia’s hub for healthcare and pharmaceuticals—with strategic alliances and high-level participation across medtech, biopharma, digital ...

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

Malaysian medical graduates are highly sought after by hospitals in Singapore, which consider them to be “cheap yet high quality assets”, according to a Malaysian doctor serving in the city-state.

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

As Malaysia continues to strengthen its position as Southeast Asia’s hub for healthcare and pharmaceuticals—with strategic alliances and high-level participation across medtech, biopharma, digital ...